by Patricia Baumgart | Aug 28, 2026 | Access by Design, Blog
PRIME, the European Medicines Agency’s (EMA) Priority Medicines (or PRIME) scheme, is a regulatory tool designed to support medicines that address unmet medical needs. For academic researchers and small development teams, using PRIME in drug development can...
